Data from previous studies suggest that HMOX1 might play different roles in many cancer pathways, including that the longer promoter GTn repeat polymorphism of HMOX1 is associated with worse prognosis in pancreatic NET patients.24 Here, HMOX1 is linked to pancreatic neuroendocrine tumor.